BRAF and melanoma: Here, we extend these observations and demonstrate that GALC overexpression plays a pro-tumorigenic function on both A2058 and A375 human melanoma cells that harbor the BRAF(V600E)-activating mutation, which is present in approximately 50% of human melanomas [6].